Author: Peter Mansell

The UK’s National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) has teamed up with the Engineering and Physical Sciences Research Council (EPSRC) to award a total of £1.5 million for the development of advanced imaging technologies.

UCB is inviting academic and research groups to submit proposals for collaborative drug-discovery projects involving antibody targets through its newly launched ‘Technology Platform Access’ programme.

ICON has revised upwards its guidance for revenues and earnings per share (EPS) in 2014, to reflect the recent acquisition of Aptiv Solutions as well as continuing margin improvement on the back of a 10% increase in revenues for the first quarter.

Cancer Research UK (CR UK) plans to increase its research funding for the diagnosis, detection, prevention and treatment of cancer by more than 50% over the next five to 10 years.

The Canadian Clinical Trials Coordinating Centre (CCTCC) has been launched with funding of Can$1,545,000 over three years and a remit to attract more clinical-research investment to Canada.